These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7351512)

  • 1. New therapies in the management of congestive heart failure.
    Atkins FL
    J Kans Med Soc; 1980 Feb; 81(2):83-5, 94. PubMed ID: 7351512
    [No Abstract]   [Full Text] [Related]  

  • 2. New approaches to managing congestive heart failure.
    Romankiewicz N
    J Pract Nurs; 1983 Jan; 33(1):13-7. PubMed ID: 6338208
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD
    J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic afterload reduction in the treatment of congestive heart failure.
    Feldman R
    J Iowa Med Soc; 1983 Nov; 73(11):466, 468, 470. PubMed ID: 6361177
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
    Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT
    Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK; Awan NA; Mason DT
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypotensive agents. Part I: Vasodilators.
    Romankiewicz JA
    J Pract Nurs; 1979 Jun; 29(6):10-2. PubMed ID: 255614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peripheral vasodilators in the treatment of hypertension. A review].
    Rasmussen K
    Ugeskr Laeger; 1979 Jan; 141(5):312-4. PubMed ID: 760314
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine.
    Hua AS; Macdonald IM; Myers JB; Fang P; Kincaid-Smith P
    Med J Aust; 1977 Jul; 2(1):5-9. PubMed ID: 331040
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
    Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
    Leier CV; Desch CE; Magorien RD; Triffon DW; Unverferth DV; Boudoulas H; Lewis RP
    Am J Cardiol; 1980 Dec; 46(6):1039-44. PubMed ID: 7446418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy for chronic congestive heart failure.
    Abrams J
    JAMA; 1985 Dec; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 16. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prazosin in refractory congestive heart failure].
    Timio M; Gentili S; Pede S; Schiaroli M
    Boll Soc Ital Cardiol; 1978; 23(4):768-76. PubMed ID: 757362
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
    Greenberg BH; Massie BM
    Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.